Nusinersen in Adult Patients with Spinal Muscular Atrophy
Neurol 95:e413-e416, Moshe-Lilie, O.,et al, 2020
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
NEJM 376:115-124, Powers, S.W.,et al, 2016
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Effect of Caudal Epidural Steroid or Saline Injection in Chronic Lumbar Radiculopathy: Multicentre, Blinded, Randomised Controlled Trial
BMJ 343:d5278,d5310, Iversen, T.,et al, 2011
Acupuncture for Chronic Low Back Pain
NEJM 363:454-461, Berman,B.M., et al, 2010
Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009
The Ethics of Thrombolytic Trials Beyond 3 (or 4.5) Hours: Randomized Controlled Trials Are Required to Change Clinical Practice
Stroke 40:1545, Donnan,G.A. &Davis,S.M., 2009
Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008
Intermittent Cyclophosphamide With Prednisone Versus Placebo for Polyneuropathy With IgM Monoclonal Gammopathy
Neurol 69:50-59, Niermeijer,J.M.F.,et al, 2007
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Treatment of Agitation in AD
Neurol 55:1271-1278,1247, Teri,L.,et al, 2000
Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999
Sumatriptan Injection Reduces Productivity Loss During a Migraine Attack
Arch Int Med 158:1013-1018, Cady,R.C.,et al, 1998
A Comparison of Divalproex with Propranolol and Placebo for the Prophylaxis of Migraine Without Aura
Arch Neurol 54:1141-1145, Kaniecki,R.G., 1997
Ethical Use of Placebos and Provocative Testing in Diagnosing Nonepileptic Seizures
Neurol 47:866-870, Devinsky,O.&Fisher,R., 1996
Streptokinase for Acute Ischemic Stroke with Relationship to Time of Administration
JAMA 276:961-966, 9951996., Donnan,G.A.,et al, 1996
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Utility and Reliability of Placebo Infusion in the Evaluation of Patients with Seizures
neurol 44:394-399, Walczak,T.S.,et al, 1994
Randomised Clinical Trial of Manipulative Therapy & PT for Persistent Back & Neck Complaints:1-Year Follow Up
BMJ 304:601-605, Koes,B.W.,et al, 1992
TENS for Chronic Low-Back Pain
Editorial, Lancet 337:462-4631991., , 1991
A Controlled Trial of Transcutaneous Electrical Nerve Stimulation (Tens) and Exercise for Chronic Low Back Pain
NEJM 322:1627-1634, Deyo,R.A.,et al, 1990
Dexamethasone is Not Superior to Placebo for Treating Lumbosacral Radicular Pain
Neurol 36:1593-1594, Haimovic,I.C.&Beresford,H.R., 1986
Controlled Comparison of Short-Wave Diathermy Treatment with Osteopathic Treatment in Non-specific Low Back Pain
Lancet 1:1258-1261, Gibons,T.,et al, 1985
Acupuncture Treatment of Chronic Back Pain, A Double-Blind Placebo-Controlled Trial
Am J Med 74:49-55, Mendelson,G.,et al, 1983
Pain II:New Approaches to Management
Ann Neurol 9:101-106, Fields,H.L., 1981
Biology of Placebo Analgesia
Am J Med 70:745-746, Fields,H.L.,et al, 1981
Analgesic Effects of Branding in Treatment of Headaches
BMJ 282:1576-1578, Branthwaite,A.,et al, 1981
Opiate Peptides
Analgesia, & the Neuroendocrine System, Editorial, BMJ 1:741-742., , 1980
The Chronic Pain Syndrome:Misconceptions & Management
Ann Int Med 93:588-596, Reuler,J.B.,et al, 1980
Rocky Mountain Spotted Fever Encephalitis and "Starry Sky" Pattern on MRI, A Case Report
Neurologist 30:34-38, Mikhaiel,J.P.,et al, 2025
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Stroke-Like Migraine Attacks After Radiation Therapy Syndrome
Neurol 104:e210203, Lubotzky,A.,t al, 2025
Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025
FUTURE-AI: International Consensus Guideline for Trustworthy and Deployable Artificial Intelligence in Healthcare
BMJ 388:e081554, Lekadir,K.,et al, 2025
A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025
Methamphetamine-Induced Basal Ganglia Toxicity Presenting as Parkinsonism
Neurol 104:e213365, Yi,M.Y.,et al, 2025
Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guideline
BMJ 388:e079970, Busse,J.W.,et al, 2025
Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma
NEJM 392:855-864, 918, Fiorella,D.,et al, 2025
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025
Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025
"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025
Calibrating AI Reliance - A Physicians Superhuman Dilemma
JAMA Health Forum 6:e250106, Patil,S.V.,et al, 2025